Navidea Biopharmaceuticals Announces Fourth Quarter and Full-Year 2012 Results

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced consolidated results for the fourth quarter of 2012 and for the year ended December 31, 2012.
MORE ON THIS TOPIC